氨甲环酸联合不同抗凝药对全膝关节置换术围手术期失血量的影响

doi:10.13418/j.issn.1001-165x.2022.3.20

中国临床解剖学杂志 ›› 2022, Vol. 40 ›› Issue (3): 356-361.doi: 10.13418/j.issn.1001-165x.2022.3.20

氨甲环酸联合不同抗凝药对全膝关节置换术围手术期失血量的影响

陈森荣^{1, 2}，肖军¹*，李强³，胡勇⁴，史占军¹

1.南方医科大学南方医院关节与骨病外科，广州 510515； 2.广东医科大学附属第三医院（佛山市顺德区龙江医院）骨科，广东佛山 523819； 3. 怀化市中医院关节外科，湖南怀化 418000； 4. 南方医科大学第五医院关节外科，广州 510900

收稿日期:2021-10-13 出版日期:2022-05-25 发布日期:2022-06-02
通讯作者: 肖军，副教授，副主任医师，E-mail：orthopaedxj@163.com
作者简介:陈森荣（1985-），男，广东佛山人，副主任医师，主要从事关节、创伤骨科研究，E-mail：alson123@126.com

Effects of tranexamic acid and different anticoagulants on perioperative blood loss in total knee arthroplasty

Chen Senrong^1,2 , Xiao Jun¹*, Li Qiang³ , Hu Yong⁴ , Shi Zhanjun¹

1. Department of Orthopedics, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China; 2. Department of Orthopedics, the Third Affiliated Hospital of Guangdong Medical University (Longjiang Hospital, Shunde District, Foshan City), Foshan 523819, China; 3. Department of Orthopedics, Huaihua Hospital of Traditional Chinese Medicine, Huaihua 418000, China; 4. Department of Orthopedics, the Fifth Hospital of Southern Medical University, Guangzhou 510900, China

Received:2021-10-13 Online:2022-05-25 Published:2022-06-02

摘要/Abstract

摘要： 目的探讨氨甲环酸与不同抗凝药联用对全膝关节置换术围手术期失血量的影响。方法纳入2014年10月至2019年10月初次行全膝关节置换术并符合标准的158例膝骨性关节炎患者，按氨甲环酸注射方法及术后使用抗凝药分为4组：A组，术中静脉注射氨甲环酸＋术后利伐沙班抗凝；B组，术中静脉注射氨甲环酸＋术后依诺肝素抗凝；C组，术中静脉＋局部注射氨甲环酸＋术后利伐沙班抗凝；D组，术中静脉＋局部注射氨甲环酸＋术后依诺肝素抗凝。各组患者一般情况、术前准备、手术方式及术后处理一致，比较其失血量、凝血功能、输血及围手术期不良事件的发生率。结果联合使用氨甲环酸的患者能有效控制总出血量、显性出血量、输血率及血浆D二聚体；术后使用利伐沙班或依诺肝素抗凝，出血量、输血率及围手术期不良事件发生率相当。结论 TKA术中应用氨甲环酸静脉＋局部注射能有效减少围手术期的失血量、输血率及血浆D二聚体；术后使用利伐沙班或依诺肝素进行抗凝，两者对失血量及围手术期不良事件发生率的影响无明显差异。

关键词: 全膝关节置换术； , , 氨甲环酸； , , 抗凝药物； , , 围手术期； , , 失血量

Abstract: Objective To investigate the effect of tranexamic acid and different anticoagulants on blood loss during the perioperative period of total knee arthroplasty. Methods A total of 158 patients with knee osteoarthritis who underwent total knee arthroplasty (TKA) from October 2014 to October 2019 and met the criteria were enrolled. According to different tranexamic acid injection methods and postoperative use of different anticoagulants, they were divided into four group: Group A: intraoperative intravenous injection of tranexamic acid + postoperative rivaroxaban anticoagulation; Group B: intraoperative intravenous injection of tranexamic acid + postoperative enoxaparin anticoagulation; Group C: intraoperative vein injection + local injection of tranexamic acid + postoperative rivaroxaban anticoagulation; Group D: intraoperative intravenous injection + local injection of tranexamic acid + postoperative enoxaparin anticoagulation. The preoperative preparations, intraoperative and postoperative treatments of the patients in each group were the same. The general information, intraoperative conditions, blood loss, blood coagulation function, blood transfusion and incidence of perioperative adverse events were compared in the four groups. Results The combined use of tranexamic acid could further reduce total bleeding, overt bleeding, blood transfusion rate and plasma D dimerization body (P<0.05). After the use of rivaroxaban for anticoagulation, the bleeding volume, blood transfusion rate and perioperative adverse event rate were equivalent to enoxaparin. Conclusions The application of intravenous tranexamic acid combined with local injection during TKA can further effectively reduce the blood loss, transfusion rate and Plasma D dimer during the perioperative period. Rivaroxaban or enoxaparin is used for anticoagulation after operation, there is no significant difference in the blood loss and the incidence rate of perioperative adverse events.

Key words: Total knee arthroplasty; , , Tranexamic acid; , Anticoagulant drugs; , , Perioperative period; , Blood loss

中图分类号:

R687.4

陈森荣, 肖军, 李强, 胡勇, 史占军. 氨甲环酸联合不同抗凝药对全膝关节置换术围手术期失血量的影响[J]. 中国临床解剖学杂志, 2022, 40(3): 356-361.

Chen Senrong , Xiao Jun, Li Qiang , Hu Yong , Shi Zhanjun . Effects of tranexamic acid and different anticoagulants on perioperative blood loss in total knee arthroplasty[J]. Chinese Journal of Clinical Anatomy, 2022, 40(3): 356-361.

参考文献 15

[1]	Fillingham YA, Ramkumar DB, Jevsevar DS, et al. The safety of tranexamic acid in total joint arthroplasty: a direct meta-analysis[J]. J Arthroplasty, 2018, 33(10): 3070-3082.e1. DOI: 10.1016/j.arth. 2018. 03. 031.
[2]	Gianakos AL, Hurley ET, Haring RS, et al. Reduction of blood loss by tranexamic acid following total hip and knee arthroplasty: a meta-analysis[J]. JBJS reviews, 2018, 6(5): e1. DOI: 10.2106/jbjs.Rvw.17.00103.
[3]	Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: american college of chest physicians evidence-based clinical practice guidelines[J]. Chest, 2012, 141(2 Suppl): e278S-e325S. DOI: 10.1378/chest.11-2404.
[4]	Mao YC, Chen ST, Chen CH, et al. Rivaroxaban in preventing venous thromboembolism after arthroplastic surgery in Taiwan[J]. Kaohsiung J Med Sci, 2015, 31(10): 534-539. DOI: 10.1016/j.kjms.2015.08.003.
[5]	Digas G, Koutsogiannis I, Meletiadis G, et al. Intra-articular injection of tranexamic acid reduce blood loss in cemented total knee arthroplasty[J]. Eur J Orthop Surg Traumatol, 2015, 25(7): 1181-1188. DOI: 10.1007/s00590-015-1664-8 .
[6]	Guo P, He Z, Wang Y, et al. Efficacy and safety of oral tranexamic acid in total knee arthroplasty: a systematic review and meta-analysis[J]. Medicine(Baltimore),2018, 97(18): e0587. DOI: 10.1097/md.00000 00000010587.
[7]	周斌, 余翀, 李毅清. 静脉血栓栓塞疾病的抗栓治疗-第10版美国胸科医师学会抗栓治疗指南解读[J]. 临床外科杂志, 2017, 25(1): 40-42. DOI: 10.3969/j.issn.1005-6483.2017.01.010.
[8]	陆慧杰, 庄汝杰, 陈之青. 利伐沙班对比依诺肝素预防骨科大手术后深静脉血栓形成的疗效与安全性评价[J]. J 中国临床药理学杂志, 2015, 000(9): 693-695. DOI: 10.13699/j.cnki.1001-6821.2015.09.004.
[9]	Wang S, Gao X, An Y. Topical versus intravenous tranexamic acid in total knee arthroplasty: a meta-analysis of randomized controlled trials[J]. Int Orthop, 2017, 41(4): 739-748. DOI: 10.1007/s00264-016-3296-y.
[10]	Tsukada S, Kurosaka K, Nishino M, et al. Intra-articular tranexamic acid as an adjunct to intravenous tranexamic acid for simultaneous bilateral total knee arthroplasty: a randomized double-blind, placebo-controlled trial[J]. BMC Musculoskelet Disord, 2019, 20(1): 464. DOI: 10.1186/s12891-019-2890-8.
[11]	Zhang YM, Lang B, Zhao GF, et al. Hemostatic effect of tourniquet combined with tranexamic acid in total knee arthroplasty: a network meta-analysis[J]. J Orthop Surg Res, 2020, 15(1): 530. DOI: 10.1186/s13018-020-02010-z.
[12]	Langner AL, Fleet JL, McArthur E, et al. Rivaroxaban vs. low molecular weight heparin for the prevention of venous thromboembolism after hip or knee arthroplasty: a cohort study[J]. J Thromb Haemost, 2014, 12(10): 1626-1635. DOI: 10.1111/jth.12675.
[13]	Kim YT, Kang MW, Lee JK, et al. Combined use of topical intraarticular tranexamic acid and rivaroxaban in total knee arthroplasty safely reduces blood loss, transfusion rates, and wound complications without increasing the risk of thrombosis[J]. BMC Musculoskelet Disord, 2018, 19(1): 227. DOI: 10.1186/s12891-018-2151-2.
[14]	Meng BY, Ma J, Liu Z, et al. Efficacy and safety of tranexamic acid combined with rivaroxaban in primary total knee arthroplasty: a meta-analysis of randomized controlled trials[J]. J Invest Surg, 2021, 34(7): 728-737. DOI: 10.1080/08941939.2019.1690602.
[15]	Jules-Elysee KM, Tseng A, Sculco T , et al. Comparison of topical and intravenous tranexamic acid for total knee replacement: a randomized double-blinded controlled study of effects on tranexamic acid levels and thrombogenic and inflammatory marker levels[J]. J Bone Joint Surg Am, 2019, 101(23): 2120-2128. DOI: 10.2106/jbjs.19.00258.

氨甲环酸联合不同抗凝药对全膝关节置换术围手术期失血量的影响

Effects of tranexamic acid and different anticoagulants on perioperative blood loss in total knee arthroplasty

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 15

相关文章 15

Metrics

本文评价

推荐阅读 0

[1]	江剑宏, 段仁鹏, 李晓锋. 国人胆道三维重建解剖变异应用研究[J]. 中国临床解剖学杂志, 2024, 42(1): 1-4.
[2]	郭红志, 王瑜, 张加琪, 梁海彬, 马梓玮, 冯伟, 吴忧, 司子燚. 血管铸型结合CT三维模型评估先兆子痫胎盘血管结构[J]. 中国临床解剖学杂志, 2024, 42(1): 5-10.
[3]	李佳伟, 张静, 李灿然, 兰文杰, 籍庆余, 郭志勇, 张云凤, 刘启, 陈清威, 李筱贺. 蒙古族人群股骨近端解剖参数X线测量[J]. 中国临床解剖学杂志, 2024, 42(1): 11-16.
[4]	李琨, 张燕, 郭冉, 郝咪咪, 吴轩宇, 徐艺芳, 王超群, 马文童, 张灵淇, 杨宏宇, 李志军, 张少杰, 王星. 儿童及青少年枕颈角与后枕颈角数字化测量及其临床意义[J]. 中国临床解剖学杂志, 2024, 42(1): 17-20.
[5]	李文, 杨思艺, 黄蕾, 卿霁雯, 蒋松涛, 张磊. 基于MRI探讨Lisfranc韧带的形态学特点及临床意义[J]. 中国临床解剖学杂志, 2024, 42(1): 21-25.
[6]	李凡凡, 徐阳, 王晓旭. 紫草素调节Nrf2/HO-1信号通路对实验性大鼠肉芽肿性小叶性乳腺炎的治疗作用研究[J]. 中国临床解剖学杂志, 2024, 42(1): 26-32.
[7]	王兴航, 丁佳媛, 李放, 包翠芬, 阎丽菁. 人参皂苷Rg1通过抑制NLRP3炎症小体途径减轻氧糖剥夺/复供后小胶质细胞炎症反应[J]. 中国临床解剖学杂志, 2024, 42(1): 33-41.
[8]	程莹莹, 武建军, 蔡海燕, 焦旭文, 马江波, 丁银秀. 体外炎性诱导星形胶质细胞激活及功能分析[J]. 中国临床解剖学杂志, 2024, 42(1): 42-46.
[9]	祁志, 杨力, 贾秋叶, 陈浩伦, 段兆达, 吴春云. 依达拉奉经MAPKs通路对脂多糖激活的小胶质细胞Sirt3表达调控[J]. 中国临床解剖学杂志, 2024, 42(1): 47-53.
[10]	张晶晶, 王洪新. 黄芩苷通过PDGF/P38 MAPK信号通路对肺动脉高压大鼠的保护作用[J]. 中国临床解剖学杂志, 2024, 42(1): 54-58.
[11]	乐钦, 陈荣丽, 熊婧熙, 王婷怡, 蔡志恒, 易秋实, 曾心怡. 白芨多糖对大鼠跨区皮瓣choke区的影响[J]. 中国临床解剖学杂志, 2024, 42(1): 59-64.
[12]	李笑予, 张磊, 付磊, 李东波, 汪国友. 三步接骨法治疗Sanders Ⅱ型跟骨骨折的有限元研究[J]. 中国临床解剖学杂志, 2024, 42(1): 65-70.
[13]	吴研飞, 马剑雄, 卢斌, 王颖, 柏豪豪, 靳洪震, 马信龙. CT后处理技术重建CT值与终板抗压强度的相关性研究[J]. 中国临床解剖学杂志, 2024, 42(1): 71-76.
[14]	庄万强, 唐毅, 骆勇刚, 张辉. 关节镜联合胫骨高位截骨术对髌骨位置及髌股关节功能影响的早中期回顾性研究[J]. 中国临床解剖学杂志, 2024, 42(1): 77-82.
[15]	罗鹰, 窦伟誉, 吴小杭, 陈璟昆, 彭昌贵, 潘剑英 . 微创海马钢板内固定治疗跟骨骨折并发症的影响因素[J]. 中国临床解剖学杂志, 2024, 42(1): 83-88.